Emcure Pharma IPO Poised for Strong Market DebutDefault Banner

Emcure Pharma IPO Poised for Strong Market Debut

Writer
Shivani Nyati
Status
online
Timer
July 10, 2024

Shivani Nyati, Head of Wealth at Swastika Investmart Ltd., mentioned that Emcure Pharmaceuticals Ltd. is expected to have a strong debut on the stock market, with the IPO generating significant interest. The grey market premium (GMP) of Rs 372 reflects a 36.9% premium over the issue price, suggesting a listing pop of around 35-37%. Nyati also noted that the IPO saw an impressive subscription rate of 67.87 times, indicating strong investor confidence.

‍

‍

  • IPO screener: Emcure Pharma listing today (The Hindu Business Line)
  • Emcure Pharma IPO shares to make stock market debut today; strong listing gains likely (Business Today)
  • Emcure Pharma IPO listing tomorrow: Will it have strong market debut? (India Today)
  • Emcure Pharma IPO listing tomorrow: Will it have strong market debut? (MSN)
  • Emcure Pharma IPO shares to make stock market debut today; strong listing gains likely (MSN)
  • Emcure Pharma to make stock market debut on Wednesday; here's what to expect as GMP corrects (MSN)

    • ‍

    No items found.
    Follow us on social media:
    Thank you! Your submission has been received!
    Oops! Something went wrong while submitting the form.